- Home
- DOMH vs SRTS Comparison
DOMH vs SRTS Comparison
Compare DOMH & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOMH | SRTS |
|---|---|---|
| Founded | 1967 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.1M | 45.6M |
| IPO Year | 2010 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DOMH | SRTS |
|---|---|---|
| Price | $1.74 | $2.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 159.5K | 17.6K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | ★ 50.40% | N/A |
| EPS Growth | ★ 34.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $123,104,000.00 | $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $41.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 578.41 | N/A |
| 52 Week Low | $1.85 | $2.66 |
| 52 Week High | $6.15 | $5.49 |
Technical Indicators
Market Signals| Indicator | DOMH | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 32.54 | 52.81 |
| Support Level | N/A | $2.97 |
| Resistance Level | $3.29 | $3.17 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 6.25 | 76.47 |
Price Performance
Historical ComparisonAbout DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.